CANG
Cango Inc.
There isn't enough reported data to score CANG yet.
NIO
NIO Inc.
NIO lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink.
CANG Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Healthy | |
| Unavailable | |
| Strong |
CANG's profitability and balance sheet are currently healthy. There isn't enough data to rate its revenue and cash flow.
NIO Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Stable | |
| Stable | |
| Unavailable |
NIO's revenue is currently strong, and its profitability and cash flow are stable. There isn't enough data to rate its balance sheet.
CANG PE Valuation
CANG has no meaningful PE right now: it lost money over the past year.
NIO PE Valuation
NIO has no meaningful PE right now: it lost money over the past year.
CANG Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong decline | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect CANG's losses to shrink, with revenue declining.
NIO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
NIO has the edge over CANG on the outlook, with more favorable revenue expectations.
CANG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2024 | $0.97 | +$1.09 |
| Q4 2023 | -$0.12 | +$2.93 |
| Q4 2022 | -$3.05 | -$3.02 |
| Q3 2022 | -$1.17 | -133% |
| Q2 2022 | -$1.89 | -121% |
| Q1 2022 | $0.30 | -96% |
| Q4 2021 | -$0.03 | -100% |
| Q3 2021 | $3.54 | -26% |
CANG has the stronger earnings trend. Trailing diluted EPS is down 49% for CANG versus NIO down 117%.
NIO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.29 | +$1.45 |
| Q1 2026 | -$0.60 | +$1.16 |
| Q4 2025 | -$1.06 | +$0.60 |
| Q3 2025 | -$1.59 | +$0.02 |
| Q2 2025 | -$1.74 | -$0.10 |
| Q1 2025 | -$1.76 | +$0.06 |
| Q4 2024 | -$1.66 | +$0.21 |
| Q3 2024 | -$1.61 | +$0.32 |
NIO is still losing money, but far less than before: $0.29 per share over the past year, against $1.93 at its worst in late 2023.
CANG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2025 | $404.1M | +235% |
| Q4 2024 | $120.7M | -53% |
| Q4 2023 | $255.4M | +249% |
| Q4 2022 | $73.1M | -54% |
| Q3 2022 | $62.5M | -48% |
| Q2 2022 | $43.4M | -69% |
| Q1 2022 | $118.2M | -30% |
| Q4 2021 | $157.7M | -4.3% |
CANG has the stronger quarterly revenue trend. Revenue is up 453% for CANG versus up 69% for NIO.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | -58% | -14 points |
| Q2 2025 | -72% | -26 points |
| Q4 2024 | 22% | +145 points |
| Q4 2023 | -4.3% | +20 points |
| Q4 2022 | -43% | -29 points |
| Q3 2022 | -46% | -41 points |
| Q2 2022 | -122% | -124 points |
| Q1 2022 | -24% | -38 points |
CANG's operating margin was −58% last quarter, down 14 points from the same quarter a year ago, near the bottom of its range since 2016.
NIO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $4.8B | +69% |
| Q1 2026 | $3.8B | +112% |
| Q4 2025 | $5.2B | +76% |
| Q3 2025 | $3.3B | +17% |
| Q2 2025 | $2.9B | +9% |
| Q1 2025 | $1.8B | +21% |
| Q4 2024 | $3B | +15% |
| Q3 2024 | $2.8B | -2.1% |
NIO's revenue has grown year over year for seven quarters in a row: $4.8B last quarter, up 69% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -2.1% | +24 points |
| Q1 2026 | -1.2% | +52 points |
| Q4 2025 | 2.3% | +33 points |
| Q3 2025 | -16% | +12 points |
| Q2 2025 | -26% | +4 points |
| Q1 2025 | -53% | +1.1 points |
| Q4 2024 | -31% | +8.1 points |
| Q3 2024 | -28% | -2.6 points |
NIO's operating margin was −2.1% last quarter, up 24 points from the same quarter a year ago.
CANG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2024 | -$46.6M | -130% |
| Q4 2023 | $153.7M | +$153.7M |
| Q4 2022 | $0 | $0 |
| Q3 2022 | $0 | $0 |
| Q2 2022 | $0 | $0 |
| Q1 2022 | $0 | $0 |
| Q4 2021 | $0 | $0 |
| Q3 2021 | $0 | $0 |
CANG has the stronger cash trend. Its trailing FCF is up 365% versus its history, compared with NIO at up 100%.
NIO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $0 | +$2.1B |
| Q1 2026 | $0 | $0 |
| Q4 2025 | $0 | +$391.3M |
| Q3 2025 | $0 | $0 |
| Q2 2025 | -$2.1B | +$73.9M |
| Q1 2025 | $0 | $0 |
| Q4 2024 | -$391.3M | -386% |
| Q2 2024 | -$2.2B | +$337.9M |
NIO's free cash flow was $0 over the past year, against −$2.5B the year before.
CANG Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -9.5% | -4.4M shares |
| 1 year | -23% | -12.4M shares |
| 3 years | -30% | -17.9M shares |
| 5 years | -17% | -8.4M shares |
| Available history | -17% | -8.4M shares |
CANG has the edge over NIO on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2024 | $13.6M |
| Q4 2023 | $37M |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | — |
| Q3 2021 | — |
NIO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.6% | +15.6M shares |
| 1 year | +12% | +267M shares |
| 3 years | +51% | +844M shares |
| 5 years | +60% | +933M shares |
| Available history | +143% | +1.5B shares |
NIO has 2.5B diluted shares, up 12% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
NIO hasn't bought back shares in the past year.
CANG Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2024 | -4.4x | Net Cash |
| Q4 2021 | 3.1x | Elevated |
| Q3 2021 | 4.0x | Elevated |
| Q2 2021 | 2.3x | Moderate |
| Q1 2021 | 1.5x | Healthy |
| Q4 2020 | 3.4x | Elevated |
| Q3 2020 | 4.0x | High |
| Q2 2020 | 0.8x | Very low |
CANG has more cash than debt.
NIO Net Leverage
NIO's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CANG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 39.8 | Neutral |
| Stochastic | 9.7 | Oversold |
CANG's weekly RSI is 40 (neutral) and its Stochastic is 10 (oversold).
NIO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.7 | Neutral |
| Stochastic | 6.9 | Oversold |
NIO's weekly RSI is 31 (neutral) and its Stochastic is 7 (oversold).
CANG PE vs Consumer Cyclical Sector
| Metric | CANG | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
CANG has no meaningful PE right now: it lost money over the past year.
NIO PE vs Consumer Cyclical Sector
NIO has no meaningful PE right now: it lost money over the past year.
CANG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.09 | 24% below |
| 20 week MA | $2.03 | 22% below |
| 50 week MA | $5.48 | 71% below |
| 100 week MA | $13.7 | 88% below |
| 200 week MA | $10.7 | 85% below |
CANG is in a downtrend: it's below all five of its weekly moving averages, and 85% below its 200-week average.
NIO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.36 | 9.2% below |
| 20 week MA | $4.01 | 24% below |
| 50 week MA | $4.81 | 37% below |
| 100 week MA | $4.85 | 37% below |
| 200 week MA | $6.03 | 49% below |
NIO is in a downtrend: it's below all five of its weekly moving averages, and 49% below its 200-week average.
CANG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $43.0 | $36.3 | -16% |
| 2021 | $36.3 | $16.1 | -56% |
| 2022 | $16.1 | $6.70 | -58% |
| 2023 | $6.70 | $5.10 | -24% |
| 2024 | $5.10 | $24.6 | +382% |
| 2025 | $24.6 | $13.9 | -43% |
| 2026 YTD | $13.9 | $1.59 | -89% |
CANG's yearly returns have swung widely, from +382% in 2024 to −58% in 2022. It's down 89% so far in 2026.
NIO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $2.42 | $45.8 | +1791% |
| 2021 | $45.8 | $30.5 | -33% |
| 2022 | $30.5 | $11.0 | -64% |
| 2023 | $11.0 | $9.07 | -17% |
| 2024 | $9.07 | $4.48 | -51% |
| 2025 | $4.48 | $5.10 | +14% |
| 2026 YTD | $5.10 | $3.05 | -40% |
NIO has the edge over CANG on returns for 2026, with the stronger performance.